B
Braidwell Portfolio holdings
AUM
$2.92B
1-Year Return
4.59%
This Quarter Return
+4.41%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.06B
AUM Growth
+$28.4M
(+0.94%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-48.03%
Top 10 Holdings %
Top 10 Hldgs %
37.02%
Holding
99
New
15
Increased
19
Reduced
16
Closed
14
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$46M |
| 2 |
Boston Scientific
BSX
|
$38.8M |
| 3 |
Viridian Therapeutics
VRDN
|
$28.7M |
| 4 |
Maravai LifeSciences
MRVI
|
$22.4M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$20.5M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$90.4M |
| 2 |
Glaukos
GKOS
|
$54.3M |
| 3 |
Amgen
AMGN
|
$39M |
| 4 |
Intuitive Surgical
ISRG
|
$34M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$29.7M |
Sector Composition
| 1 | Healthcare | 54.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mineralys Therapeutics
MLYS
$2.2B
| $9.38M | 0.31% |
550,300
| – | – |
|
|
MRTX
52
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.69M | 0.28% |
240,625
-211,375
| -47% | -$7.64M |
|
|
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.18M | 0.27% |
+42,497
| New | +$8.18M |
|
|
AGEN
54
Agenus
AGEN
$137M
| $7.52M | 0.25% |
+234,897
| New | +$7.52M |
|
55
Nuvation Bio
NUVB
$1.17B
| $7.42M | 0.24% |
4,122,900
| – | – |
|
56
Adaptive Biotechnologies
ADPT
$1.98B
| $4.35M | 0.14% |
648,451
| – | – |
|
57
Esperion Therapeutics
ESPR
$510M
| $1.25M | 0.04% |
895,949
-315,570
| -26% | -$439K |
|
58
Alphatec Holdings
ATEC
$2.45B
| $457K | 0.01% |
+25,431
| New | +$457K |
|
59
Arcellx
ACLX
$4B
| – | – |
-333,800
| Closed | -$10.3M |
|
|
60
Amgen
AMGN
$151B
| – | – |
-161,500
| Closed | -$39M |
|
61
argenx
ARGX
$44.9B
| – | – |
-24,600
| Closed | -$9.17M |
|
62
Avalo Therapeutics
AVTX
$134M
| – | – |
-1,030
| Closed | -$433K |
|
63
Globus Medical
GMED
$8.14B
| – | – |
-335,200
| Closed | -$19M |
|
64
Immatics
IMTX
$695M
| – | – |
-322,287
| Closed | -$2.22M |
|
65
Mersana Therapeutics
MRSN
$35.5M
| – | – |
-134,232
| Closed | -$13.8M |
|
66
Pacific Biosciences
PACB
$372M
| – | – |
-1,097,300
| Closed | -$12.7M |
|
67
Syndax Pharmaceuticals
SNDX
$1.39B
| – | – |
-920,049
| Closed | -$19.4M |
|
68
Steris
STE
$24B
| – | – |
-95,694
| Closed | -$18.3M |
|
69
Transmedics
TMDX
$3.55B
| – | – |
-98,459
| Closed | -$7.46M |
|
|
SILK
70
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-63,331
| Closed | -$2.48M |
|
|
ISEE
71
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-3,714,672
| Closed | -$90.4M |
|
|
BLU
72
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-4,126,194
| Closed | -$29.7M |
|